4th Quarter - Report

TIBER CREEK GROUP for VERTEX PHARMACEUTICALS

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing. H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act

LobbyistCovered position, as disclosed
JONATHON JONES —
ASHLI PALMER —
SEAN RICHARDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.